The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Aspergillus Section Fumigati : Antifungal Susceptibility Patterns and Sequence-Based Identification
Open accessAbstract
This study analyzed 28 Aspergillus strains belonging to the section Fumigati that were isolated from clinical samples in Spain. All isolates sporulated slowly and were unable to grow at 48°C. Phylogenetic analysis based on sequencing of partial sequences of the β-tubulin and rodlet A genes was used to classify the 28 strains into six different clades ( Neosartorya hiratsukae , Neosartorya pseudofischeri , Aspergillus viridinutans , Aspergillus lentulus , Aspergillus fumigatiaffinis , and Aspergillus fumisynnematus ). Antifungal susceptibility testing showed heterogeneous patterns and grouped the strains together by species. Most A. lentulus and A. fumigatiaffinis isolates showed high MICs of amphotericin B (geometric mean [GM] MICs, ≥4.5 μg/ml), itraconazole (GM MICs, ≥6 μg/ml), voriconazole (GM MICs, ≥3 μg/ml), and ravuconazole (GM MICs, ≥3 μg/ml); N pseudofischeri and A. viridinutans showed high MICs of itraconazole (GM MICs, ≥8 μg/ml), voriconazole (GM MICs, ≥3.33 μg/ml), and ravuconazole (GM MICs, ≥2 μg/ml); and N. hiratsukae and A. fumisynnematus were susceptible to all the antifungals tested. In conclusion, a number of different species whose morphological features resemble those of Aspergillus fumigatus could succeed in producing invasive infections in the susceptible host. In addition, some of them showed high MICs for most of the antifungals available for the treatment of patients infected with these organisms. The epidemiology and clinical relevance of these species should therefore be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hussain, H. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmc076105 · Cited by 36
RetractedNational Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Aspergillus fumigatus and Aspergillosis
Latgé, J.-P. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.310 · Cited by 2,307
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,557
de Hoog, S., Guarro, J., Gené, J., & Figueras, M. J. (2000) · UvA-DARE (University of Amsterdam) · Cited by 1,427
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Aspergillus flavus: human pathogen, allergen and mycotoxin producer
Hedayati, M. T., Pasqualotto, A. C., Warn, P. A., Bowyer, P., & Denning, D. W. (2007) · Microbiology · doi:10.1099/mic.0.2007/007641-0 · Cited by 964
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
Perfect, J. R., Marr, K. A., Walsh, T. J., Greenberg, R. N., DuPont, B., de la Torre‐Cisneros, J., Just‐Nubling, G., Schlamm, H. T., Lutsar, I., Espinel‐Ingroff, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/374557 · Cited by 680
Mellado, E., Garcia-Effron, G., Alcázar-Fuoli, L., Melchers, W. J. G., Verweij, P. E., Cuenca-Estrella, M., & Rodríguez-Tudela, J. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01092-06 · Cited by 490 · cited 1×
“fumigatus strains showing resistance to azole drugs have been reported, although they have always maintained low amphotericin B MICs (11, 25, 26).”
BackgroundSelf-citationAspergillus lentulus sp. nov., a New Sibling Species of A. fumigatus
Balajee, S. A., Gribskov, J. L., Hanley, E., Nickle, D., & Marr, K. A. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.3.625-632.2005 · Cited by 404
Multiple-Triazole–Resistant Aspergillosis
Verweij, P. E., Mellado, E., & Melchers, W. J. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmc061720 · Cited by 380
Self-citationInvasive Aspergillosis in 2002: An Update
Kontoyiannis, D., & Bodey, G. (2002) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0699-z · Cited by 326
Novel Neosartorya species isolated from soil in Korea
Hong, S.-B., Cho, H.-S., Shin, H.-D., Frisvad, J. C., & Samson, R. A. (2006) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.63980-0 · Cited by 302
Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1120-1124.2003 · Cited by 281
Self-citationEpidemiology and outcome of infections due to Aspergillus terreus : 10‐year single centre experience
Lass‐Flörl, C., Griff, K., Mayr, A., Petzer, A., Gastl, G., Bonatti, H., Freund, M., Kropshofer, G., Dierich, M. P., & Nachbaur, D. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05763.x · Cited by 266
Ochratoxin production by Aspergillus species
Varga, J., Kevei, E., Rinyu, E., Téren, J., & Kozakiewicz, Z. (1996) · Applied and Environmental Microbiology · doi:10.1128/aem.62.12.4461-4464.1996 · Cited by 249
Genes y moléculas implicados en la virulencia de Aspergillus fumigatus
Rementeria, A., López-Molina, N., Ludwig, A., Vivanco, A. B., Bikandi, J., Pontón, J., & Garaizar, J. (2005) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(05)70001-2 · Cited by 240
Mellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2747-2750.2004 · Cited by 210
Self-citationMolecular Studies Reveal Frequent Misidentification of Aspergillus fumigatus by Morphotyping
Balajee, S. A., Nickle, D., Varga, J., & Marr, K. A. (2006) · Eukaryotic Cell · doi:10.1128/ec.00162-06 · Cited by 207
Pryce, T. M., Palladino, S., Kay, I. D., & Coombs, G. W. (2003) · Medical Mycology · doi:10.1080/13693780310001600435 · Cited by 206
Susceptibility Patterns and Molecular Identification of Trichosporon Species
Rodriguez-Tudela, J. L., Diaz-Guerra, T. M., Mellado, E., Cano, V., Tapia, C., Perkins, A., Gomez-Lopez, A., Rodero, L., & Cuenca-Estrella, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4026-4034.2005 · Cited by 179
Self-citationOld and new concepts of species differentiation inAspergillus
Samson, R. A., Hong, S., & Frisvad, J. C. (2006) · Medical Mycology · doi:10.1080/13693780600913224 · Cited by 157
Acquired itraconazole resistance in Aspergillus fumigatus
Dannaoui, É. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.333 · Cited by 144
Petrikkou, E., Rodrı́guez-Tudela, J. L., Cuenca-Estrella, M., Gómez, A., Molleja, A., & Mellado, E. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1345-1347.2001 · Cited by 134 · cited 2×
“The modifications included the use of RPMI 1640 with L-glutamine buffered to pH 7 with 0.165 M morpholinepropanesulfonic acid and 10 M NaOH and supplemented with 2% glucose (Oxoid) and the use of an inoculum size of 1 105 to 5 105 CFU/ml (20, 31, 34).”
MethodSelf-citationMistaken Identity: Neosartorya pseudofischeri and Its Anamorph Masquerading as Aspergillus fumigatus
Balajee, S. A., Gribskov, J. L., Brandt, M. E., Ito, J. I., Fothergill, A. W., & Marr, K. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.12.5996-5999.2005 · Cited by 134
Aspergillus Cyclooxygenase-Like Enzymes Are Associated with Prostaglandin Production and Virulence
Tsitsigiannis, D. Ι., Bok, J.-W., Andes, D. R., Nielsen, K. F., Frisvad, J. C., & Keller, N. P. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.4548-4559.2005 · Cited by 125
Azole Cross-Resistance in Aspergillus fumigatus
Mosquera, J., & Denning, D. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.556-557.2002 · Cited by 121
Aspergillus fumigatusVariant with Decreased Susceptibility to Multiple Antifungals
Balajee, S. A., Weaver, M., Imhof, A., Gribskov, J. L., & Marr, K. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1197-1203.2004 · Cited by 113
Yaguchi, T., Horie, Y., Tanaka, R. J., Matsuzawa, T., Itô, J., & Nishimura, K. (2007) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.48.37 · Cited by 110
Chryssanthou, E. (1997) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549709011864 · Cited by 105
In Vitro Analyses, Animal Models, and 60 Clinical Cases of Invasive Aspergillus terreus Infection
Steinbach, W. J., Perfect, J. R., Schell, W. A., Walsh, T. J., & Benjamin, D. K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3217-3225.2004 · Cited by 101
Gómez‐López, A., García‐Effrón, G., Mellado, E., Monzón, A., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3085-3088.2003 · Cited by 81
Self-citationRodriguez-Tudela, J. L., Chryssanthou, E., Petrikkou, E., Mosquera, J., Denning, D. W., & Cuenca-Estrella, M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5236-5237.2003 · Cited by 79
Self-citationAntifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology
Lass-Flörl, C., Cuenca-Estrella, M., Denning, D. W., & Rodriguez-Tudela, J. L. (2006) · Medical Mycology · doi:10.1080/13693780600779401 · Cited by 69
Self-citationAlcázar‐Fuoli, L., Mellado, E., García‐Effrón, G., Buitrago, M. J., López, J. F., Grimalt, J. O., Cuenca-Estrella, J. M., & Rodríguez-Tudela, J. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.453-460.2006 · Cited by 69
Self-citationMitochondrial Cytochrome b Gene Analysis of Aspergillus fumigatus and Related Species
Wang, L., Yokoyama, K., Miyaji, M., & Nishimura, K. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.4.1352-1358.2000 · Cited by 64
Mitchell, C. G., Slight, J., & Donaldson, K. (1997) · Thorax · doi:10.1136/thx.52.9.796 · Cited by 62
Alastruey‐Izquierdo, A., Cuenca‐Estrella, M., Monzón, A., & Rodríguez-Tudela, J. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01177-06 · Cited by 58
Self-citationIsolation of Neosartorya pseudofischeri from Blood: First Hint of Pulmonary Aspergillosis
Järv, H., Lehtmaa, J., Summerbell, R. C., Hoekstra, E. S., Samson, R. A., & Naaber, P. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.925-928.2004 · Cited by 56
Kontoyiannis, D. P., Bodey, G., Hanna, H. A., Hachem, R. Y., Boktour, M. R., GIRGAWAY, E., Mardani, M., & RAAD, I. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000149386 · Cited by 52
Phylogenetic analysis of newly described Neosartorya species
Varga, J., Vida, Z., Tóth, B., Debets, A. J. M., & Horie, Y. (2000) · Antonie van Leeuwenhoek · doi:10.1023/a:1002476205873 · Cited by 49
Mellado, E., Alcázar‐Fuoli, L., García‐Effrón, G., Alastruey‐Izquierdo, A., Cuenca‐Estrella, M., & Rodríguez-Tudela, J. L. (2006) · Medical Mycology · doi:10.1080/13693780600902243 · Cited by 46
Self-citationUicker, W. C., McCracken, J. P., & Buchanan, K. L. (2006) · Medical Mycology · doi:10.1080/13693780500088424 · Cited by 44
Matsuda, H., KOHNO, S., Maesaki, S., Yamada, H., Koga, H., Tamura, M., Kuraishi, H., & Sugiyama, J. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.8.1999-2005.1992 · Cited by 36
Aspergillus and aspergillosis–Progress on many fronts
Denning, D. W. (2006) · Medical Mycology · doi:10.1080/13693780600931192 · Cited by 13
Cited by
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationEpidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
Carolus, H., Pierson, S., Lagrou, K., & Van Dijck, P. (2020) · Journal of Fungi · doi:10.3390/jof6040321 · Cited by 349
Balajee, S. A., Borman, A. M., Brandt, M. E., Cano, J., Cuenca-Estrella, M., Dannaoui, E., Guarro, J., Haase, G., Kibbler, C. C., Meyer, W., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01685-08 · Cited by 326
Self-citationBalajee, S. A., Kano, R., Baddley, J. W., Moser, S. A., Marr, K. A., Alexander, B. D., Andes, D., Kontoyiannis, D. P., Perrone, G., Peterson, S., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01070-09 · Cited by 302
Metadata
- Authors
- Alcazar-Fuoli, L., Mellado, E., Alastruey-Izquierdo, A., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-04
- Volume
- 52
- Issue
- 4
- Pages
- 1244-1251
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2074866161
- Cited by
- 258
- References
- 45
- FWCI
- 13.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.